NewTimeSpace News: Hangzhou Tigermed Consulting Co., Ltd. (03347.HK) announced that on May 12, 2026, Mr. Ye Xiaoping and Ms. Cao Xiaochuan, Directors and Controlling Shareholders of the Company, received case filing notices from the CSRC. Suspected of violating information disclosure regulations in relation to shareholding changes, the two individuals are placed under official investigation. The Board believes the Group’s business operations remain normal and will not be adversely affected.
NewTimeSpace News: Powerlong Real Estate Holdings Limited (01238.HK) announced that the scheme meeting was duly held on May 12, 2026. A total of 454 scheme creditors, holding voting scheme claims of principal and accrued unpaid interest amounting to approximately US$3.256 billion (representing about 96.0% of the total voting scheme claims), participated. Among them, 445 (approximately 89.5%) voted in favour of the scheme, which has obtained the approval of the requisite majority of scheme creditors. The Company now seeks court approval and sanction of the scheme.
NewTimeSpace News: May 12, 2026, JD-SW(09618.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 315.69 billion, increased by 4.85% YoY
NewTimeSpace News: China Intelligent Health Holdings Limited (00348.HK) announced that its subsidiary Future Empire disposed of 3,350,000 shares of Huanxi Media (01003.HK) on the Stock Exchange of Hong Kong on May 12, 2026. The total consideration, excluding transaction costs, amounted to approximately HK$853,000, representing an average disposal price of HK$0.255 per share. Together with the previous disposal of 10.18 million shares, the transactions collectively constitute a discloseable transaction.
NewTimeSpace News: May 12, 2026, TME-SW(01698.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 7.9 billion, increased by 7.33% YoY
NewTimeSpace News: May 12, 2026, JD LOGISTICS(02618.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 60.58 billion, increased by 28.99% YoY
NewTimeSpace News: Pop Mart International Group Limited (09992.HK) announced its latest business performance for the first quarter of 2026. Unaudited overall revenue increased 75%–80% year-on-year. Revenue in China rose 100%–105% year-on-year, online channels in China surged 150%–155% year-on-year, Asia Pacific (excluding China) rose 25%–30% year-on-year, Americas rose 55%–60% year-on-year, and Europe and other regions rose 60%–65% year-on-year.
NewTimeSpace News: By the close of trading on May 12, 2026, WELLCELL HOLD(02477.HK) saw a gain of 24.46% in its share price, closing at HKD 5.19. During the session, it reached an intraday high of HKD 5.3 and touched an intraday low of HKD 4.03.
NewTimeSpace News, May 12, 2026, TUYA-W(02391.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at USD 80.88 million, increased by 8.29% YoY
NewTimeSpace News: OxPay Financial announced on May 11 that by subscribing for 349,000 new shares, the Company has increased the issued and paid-up capital of its wholly-owned subsidiary Oxygen7 Pte Ltd from US$1000 to US$350000.
NewTimeSpace News, May 11,Ellipsiz disclosed in an announcement that it has received a partial payment of S$3 million from Unicore for the third tranche subscription consideration.
NewTimeSpace News, May 11,SIA Engineering Company Limited disclosed in an announcement that its wholly-owned subsidiary, NexGen Network (2) Holding Pte. Ltd. (NGN2), has been placed under voluntary liquidation with liquidators appointed.
NewTimeSpace News: Trendlines disclosed in an announcement dated May 11 that the company’s Audit Committee and Board of Directors have approved an investment by an LH affiliate into portfolio companies Ceretrieve Ltd. and Vensica Medical Ltd.
NewTimeSpace News, May 11,OUE Limited disclosed in an announcement that its wholly-owned subsidiary, OUE Treasury Pte. Ltd., proposes to issue S$150 million 3.25% green notes due 2033.
NewTimeSpace News: Jiangsu Hengrui Pharmaceuticals Co., Ltd. (01276.HK) announced that it has signed a global strategic collaboration and license agreement with Bristol Myers Squibb (BMS) on May 12, 2026, to jointly advance 13 early-stage projects covering oncology, hematology, and immunology.BMS will pay Hengrui an upfront payment and annual payments of up to US$950 million. The potential total transaction value is approximately US$15.2 billion, including milestone payments.
NewTimeSpace News: Suzhou Riborn Biotech Co., Ltd. (06938.HK) announced that its core product vortosiran (RBD4059) has successfully submitted a Phase 2b Clinical Trial Application (CTA) to the European Medicines Agency (EMA) for the prevention and treatment of venous thromboembolism (VTE).Vortosiran is the world’s most advanced small nucleic acid drug targeting FXI. It has previously completed a Phase 2a clinical trial in Europe for coronary artery disease.
